Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

Hangzhou Biotest Biotech Revenue

Hangzhou Biotest Biotech had revenue of 97.49M CNY in the quarter ending September 30, 2026, a decrease of -6.96%. This brings the company's total for the last twelve months to 452.12M, down -5.55% year-over-year. In the year 2025, Hangzhou Biotest Biotech had annual revenue of 448.01M, down -19.91%. That makes Hangzhou Biotest Biotech the 25,679th largest company in the world by revenue and 4,553rd in China.

• Revenue (ttm): 452.12M
• Revenue Growth: -5.55%
• P/S Ratio: 12.01
• Revenue / Employee: 756.05K
• Employees: 598
• Market Cap: 5.41B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 329.60M 73.6%
• China 118.41M 26.4%

Fiscal year ended Dec 31, 2025 See the full Hangzhou Biotest Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	448.01M	-111.39M	-19.91%
Dec 31, 2024	559.40M	117.29M	26.53%
Dec 31, 2023	442.11M	-1.46B	-76.75%
Dec 31, 2022	1.90B	83.07M	4.57%
Dec 31, 2021	1.82B	952.70M	110.09%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error